Increased Cardiometabolic Risk in Dynapenic Obesity: Results from the Study of Workers' Health (ESAT).

Autor: Carvalho MO; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil., Duque AP; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil., Huguenin GVB; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil.; Nutrition and Dietetics Department, Fluminense Federal University, Niterói 24020-140, RJ, Brazil., Felix Mediano MF; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil.; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil., Rodrigues Júnior LF; Education and Research Department, National Institute of Cardiology, Rio de Janeiro 22240-002, RJ, Brazil.; Department of Physiological Sciences, Federal University of the State of Rio de Janeiro, Rio de Janeiro 20211-010, RJ, Brazil.

Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2024 Sep 18; Vol. 14 (9). Date of Electronic Publication: 2024 Sep 18.

Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol.

Autor: Nascimento PMC; National Institute of Cardiology, Rio de Janeiro, Brazil.; Fluminense Federal University, Niterói, Brazil., Rodrigues Junior LF; National Institute of Cardiology, Rio de Janeiro, Brazil.; Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil., Felix Mediano MF; National Institute of Cardiology, Rio de Janeiro, Brazil.; Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Gonçalves da Silva V; National Institute of Cardiology, Rio de Janeiro, Brazil., Tura BR; National Institute of Cardiology, Rio de Janeiro, Brazil., Nogueira FCS; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Domont G; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Carvalho AB; National Institute of Cardiology, Rio de Janeiro, Brazil.; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., de Carvalho ACC; National Institute of Cardiology, Rio de Janeiro, Brazil.; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Kasai-Brunswick TH; National Institute of Cardiology, Rio de Janeiro, Brazil.; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Mesquita CT; Fluminense Federal University, Niterói, Brazil., Junior HV; Fluminense Federal University, Niterói, Brazil., Rey HCV; National Institute of Cardiology, Rio de Janeiro, Brazil.

Publikováno v: PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0300918. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).

Current Treatment of Chagas Disease.

Autor: Álvarez-Hernández, Diego-Abelardo, Castro-Rico, Zaira-Leticia, García-Rodríguez-Arana, Rodolfo, González-Chávez, Alberto-Manuel, González-Chávez, Mario-Andrés, Martínez-Juárez, Luis-Alberto, Ferreira, Claudia, Vázquez-López, Rosalino

Publikováno v: Current Treatment Options in Infectious Diseases; 2020, Vol. 12 Issue 4, p438-457, 20p

Chagas Disease : A Clinical Approach

Autor: Jaime Marcelo Altcheh, Hector Freilij

Chagas disease is a potentially life threatening condition that was historically mainly endemic to Latin America. Over the last decade, however, the disease has spread to and is increasingly prevalent in other continents such as North America and Eur